HALIFAX, June 27 /CNW/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine
development company, has awarded the Warwick Kimmins Science Scholarship today
to Samantha Silliker. Samantha is graduating from Westisle Composite High
School in PEI and will be attending Dalhousie University in September.
"To win this scholarship Samantha wrote a compelling essay on her belief
that a future breakthrough in stem cell research will help find a cure for
cancer," said Brian Lowe, Vice President of IVT.
"She is an excellent student with genuine interest in scientific
research. We are pleased to offer her this scholarship in memory of Warwick
Kimmins and wish her well in pursuing her Bachelor of Science degree,"
Samantha's family has been affected by cancer and now she is taking up
the fight, acting as co-chair of her high school's Relay for Life cancer
fundraiser. She is also a talented soccer and rugby player, figure skater and
a volunteer coach.
The scholarship is in memory of IVT's founder, Dr. Warwick Kimmins.
Kimmins, was the former Dean of the Faculty of Science at Dalhousie University
and was instrumental in bringing IVT to where it is today.
ImmunoVaccine Technologies Inc. is a private, clinical-stage, vaccine
development company. Through its own biotech research, patented VacciMax(R)
and DepoVax(TM) technologies, and collaborations with partners, IVT creates
vaccines with the potential to help save and improve lives around the world.
In December 2007, IVT signed a binding MOU to acquire Pennsylvania-based
Immunotope Inc. The acquisition enables IVT to create an entire pipeline of
proprietary therapeutic cancer and infectious-disease specific vaccines. In
January 2008, IVT licensed its technology to Pfizer Animal health, marking a
pivotal step in achieving its vision of delivering breakthrough vaccines.
For further information:
For further information: Brian Lowe, Vice President IVT, (902) 492-1819,
email@example.com; Jennifer Ayotte, Communications, (902) 209-4704,